The dot blot experiment was conducted with the conformational antibody GT3818, which specifically recognizes AD-tau fibrils and does not probe monomeric tau or D-peptide controls (Extended Data Fig. 1b). This evidence concerns the gene MAPT and Alzheimer disease.